Designed to combat a health problem with a high mortality rate, this possible Ebola vaccine seeks to curb another future viral hemorrhagic outbreak.
Confirmed. World Health Organization (WHO) recently greenlighted a potential new Ebola vaccine; or, rather, the strain responsible for the latest epidemic of the Ebola virus, which has already recorded a minimum of 55 victims.
What is Ebola?
Severe and deadly most of the time as indicated by this encyclopedia doctor, Ebola is a virulent disease caused by a pathogen, which in its spread affects humans and primates, causing fever and vomiting, diarrhea and bleeding in those who suffer from it… among many other worrying symptoms.
First discovered in 1976 on the banks of the Ebola River, located in the Democratic Republic of the Congo, Ebola has manifested itself several times following small outbreaks, the one that occurred in March 2014 in West Africa was the worst of them all, killing nearly 40 percent of their afflicted.
Despite being a virus, Ebola doesn’t spread as easily between humans as it does cold Common or the flu, the measles or covid-19. Its transmission begins when the symptoms appear, in fact, through direct contact with infected body fluids such as saliva or urine, feces or sweat, vomit and semen, and also through contact with breast milk, which normally enters the body through a break of the skin or through the mucous membranes of the eyes, nose and mouth.
Finally, it should be added that the ebolavirus can also be transmitted between people through contact with ANY type of surface, whether they are materials or objects, needles or bandages or clothing, as long as they have been in contact with the bodily fluids of a sick person. of this evil
What are the promised benefits of the new Ebola vaccine?
After 80 days of health crisis, Uganda has chosen to test the first possible vaccine against the strain of ebolavirus that has been afflicting the country for months, but not before receiving support from the WHO. We are talking about an outbreak that has already caused the death of 55 people, and which at least, including two bathrooms, as well as infecting another 150.
This is a clinical trial whose coordination is the responsibility of the United Nations health agency, among others, which started with 1,200 doses of a pharmaceutical combination carried out by the Sabin Institute against the Ebola strain of Sudan, as responsible . for causing the current outbreak for which there has been no vaccine…until now, contrary to what happened with the Zaire strain.
“Working together to rapidly evaluate vaccines brings benefits now and in the future”, and this was stated during the announcement of the start of the trial by Tedros Adhanom, WHO director-general, who in the following line applauded the inventive, describing it as a good response internationally, and then comparing it to the seven months it took in 2015 to start a similar process in Guinea.
baptized as “Eliminate Ebola”which would come to mean something like “solidarity against Ebola”, the experimentation of this new possible vaccine against Ebola is directed by the Makerere University of Uganda, also co-sponsored by WHO and the Ugandan Ministry of Health. In addition, it will also have two other drug combinations, as detailed by the same health organization, made one by the Merck company, and the other by the University of Oxford, the Jenner Institute yes Serum Institute of India.
A health operation which, among other things, already has nine research teams in the field from nine districts of none other than Uganda, the region that has suffered the most from the spread of this disease.
And although the last notification of new Ebola cases in this area was on November 27 of this year, according to data from the United Nations health agency, this clinical trial of a possible new Ebola vaccine has nothing more goal that to be able to inoculate the resulting serum to “contacts of recently confirmed cases”, in the words of the WHO, who will be “guests”, while always following the relevant “ethical” measures.
